Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation (PRCT) Stock Overview

Explore PROCEPT BioRobotics Corporation’s financial performance, market position, analyst ratings, and future outlook.

PRCT●NASDAQ
HealthcareMedical - Devices
$21.95
$0.70(3.29%)
U.S. Market opens in 3h 6m

PROCEPT BioRobotics Corporation (PRCT)

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-11.41
EPS (TTM)$-1.94
ROE-0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$21.93
3 Months$16.37
1 Year Target$0.28

PRCT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, PROCEPT BioRobotics Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PRCT on the NASDAQ shows an RSI of 59.13, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.28 for the NASDAQ listing.

Key metrics behind PROCEPT BioRobotics Corporation's NASDAQ-traded stock include a P/E ratio of -11.41 and a market capitalization of 1.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRCT on the NASDAQ.

Price Performance (NASDAQ: PRCT)

1-Day Change
3.29%
5-Day Change
9.53%
1-Month Change
3.44%
3-Month Change
-14.59%
6-Month Change
-21.01%
Year-to-Date (YTD) Change
-30.23%
1-Year Change
-45.64%
3-Year Change
-32.61%
5-Year Change
-47.66%
All-Time (Max) Change
-47.66%

Contact Information

https://www.procept-biorobotics.com
650 232 7200
150 Baytech Drive, San Jose, CA, 95134

Company Facts

8,880 Employees
IPO DateSep 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions